Literature DB >> 12780833

A systematic review and meta-analysis of familial prostate cancer risk.

L E Johns1, R S Houlston.   

Abstract

OBJECTIVE: To identify published studies quantifying familial prostate cancer risks in relatives of prostate cancer cases and, by meta-analysis, obtain more precise estimates of familial risk according to the family history.
METHODS: Thirteen case-control and cohort studies were identified which have reported risks of prostate cancer in relatives of prostate cancer cases. Pooled estimates of risk for various categories of family history were obtained by calculating the weighted average of the log relative risk (RR) estimates from studies.
RESULTS: The pooled RR (95% confidence interval) in first-degree relatives was 2.5 (2.2-2.8). There was evidence that this was highest in relatives of cases diagnosed before age 60 years and that RRs declined with age. The risk for the few men with two affected relatives was increased 3.5-fold (2.6-4.8). RRs to sons of cases appeared to be lower than in brothers; a complete explanation of this observation is uncertain.
CONCLUSION: Men with a family history of prostate cancer have a significantly greater risk of developing prostate cancer than those with no such history. Risks are greatest for relatives of cases diagnosed when young and those with more than one relative affected.

Entities:  

Mesh:

Year:  2003        PMID: 12780833     DOI: 10.1046/j.1464-410x.2003.04232.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  68 in total

1.  [Risks and prevention of prostate cancer. Commentary on the new S3 guideline].

Authors:  B J Schmitz-Dräger; E Bismarck; G Lümmen
Journal:  Urologe A       Date:  2010-02       Impact factor: 0.639

2.  Number of prostate cancer risk alleles may identify possibly 'insignificant' disease.

Authors:  Brian T Helfand; Stacy Loeb; Donghui Kan; William J Catalona
Journal:  BJU Int       Date:  2010-12       Impact factor: 5.588

3.  Prostate cancer risk in men with prostate and breast cancer family history: results from the REDUCE study (R1).

Authors:  J-A Thomas; L Gerber; D M Moreira; R J Hamilton; L L Bañez; R Castro-Santamaria; G L Andriole; W B Isaacs; J Xu; S J Freedland
Journal:  J Intern Med       Date:  2012-01-16       Impact factor: 8.989

4.  Testing for the recurrent HOXB13 G84E germline mutation in men with clinical indications for prostate biopsy.

Authors:  Florian R Schroeck; Kimberly A Zuhlke; Javed Siddiqui; Rabia Siddiqui; Kathleen A Cooney; John T Wei
Journal:  J Urol       Date:  2012-10-02       Impact factor: 7.450

5.  The impact of a family history of prostate cancer on the prognosis and features of the disease in Korea: results from a cross-sectional longitudinal pilot study.

Authors:  Kwang Suk Lee; Kyo Chul Koo; Byung Ha Chung
Journal:  Int Urol Nephrol       Date:  2017-09-13       Impact factor: 2.370

6.  Genetic score is an objective and better measurement of inherited risk of prostate cancer than family history.

Authors:  Jielin Sun; Rong Na; Fang-Chi Hsu; S Lilly Zheng; Fredrik Wiklund; Lynn D Condreay; Jeffery M Trent; Jianfeng Xu
Journal:  Eur Urol       Date:  2012-12-05       Impact factor: 20.096

7.  Impact of a family history of prostate cancer on clinicopathologic outcomes and survival following radical prostatectomy.

Authors:  Mary E Westerman; Boris Gershman; R Jeffrey Karnes; R Houston Thompson; Laureano Rangel; Stephen A Boorjian
Journal:  World J Urol       Date:  2015-12-09       Impact factor: 4.226

8.  Fine mapping and functional analysis of a common variant in MSMB on chromosome 10q11.2 associated with prostate cancer susceptibility.

Authors:  Hong Lou; Meredith Yeager; Hongchuan Li; Jesus Gonzalez Bosquet; Richard B Hayes; Nick Orr; Kai Yu; Amy Hutchinson; Kevin B Jacobs; Peter Kraft; Sholom Wacholder; Nilanjan Chatterjee; Heather Spencer Feigelson; Michael J Thun; W Ryan Diver; Demetrius Albanes; Jarmo Virtamo; Stephanie Weinstein; Jing Ma; J Michael Gaziano; Meir Stampfer; Fredrick R Schumacher; Edward Giovannucci; Geraldine Cancel-Tassin; Olivier Cussenot; Antoine Valeri; Gerald L Andriole; E David Crawford; Stephen K Anderson; Margaret Tucker; Robert N Hoover; Joseph F Fraumeni; Gilles Thomas; David J Hunter; Michael Dean; Stephen J Chanock
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-21       Impact factor: 11.205

9.  Awareness of prostate cancer among patients and the general public: results of an international survey.

Authors:  J M Fitzpatrick; R S Kirby; C L Brough; A L Saggerson
Journal:  Prostate Cancer Prostatic Dis       Date:  2009-07-21       Impact factor: 5.554

10.  Comprehensive resequence analysis of a 97 kb region of chromosome 10q11.2 containing the MSMB gene associated with prostate cancer.

Authors:  Meredith Yeager; Zuoming Deng; Joseph Boland; Casey Matthews; Jennifer Bacior; Victor Lonsberry; Amy Hutchinson; Laura A Burdett; Liqun Qi; Kevin B Jacobs; Jesus Gonzalez-Bosquet; Sonja I Berndt; Richard B Hayes; Robert N Hoover; Gilles Thomas; David J Hunter; Michael Dean; Stephen J Chanock
Journal:  Hum Genet       Date:  2009-12       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.